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or patients at high risk with slow progression of chylo- 
pericardium. 
Unlike chylothorax, chylopericardium should not result 
in visible leakage of the thoracic duct. Therefore intraop- 
erative attempts at duct visualization seems nonessential. 
We favor "mass ligation," as recommended by Murphy 
and Piper, 4 allowing a complete interruption of all possi- 
ble lymphatic vessels, especially in the case of double or 
triple ducts at this level. 5 For this technique the right- 
sided approach is more appropriate and is preferred by 
most authors. 6 
In our patient the minimal amount of loculated 
pericardial fluid was on the right side and hardly visible 
on echocardiographic follow-up after 1 month. We do 
not believe that this fluid is related to the size of the 
pericardial window, as suggested by Yiiksel and coau- 
thors, because we had performed a partial pericardiec- 
tomy of 7 × 5 cm on the right side. In our experience, 
the extent of pericardial fenestration on the left is also 
limited by the inherent possibility of heart herniation 
through the pericardium. Long-term follow-up was not 
suggested in our report, but we can update our case 
report now by an uneventual radiologic and clinical 
2-year follow-up. 
Markus Furrer, MD 
Department of Thoracic~Cardiovascular Surgery 
University of Bern 
Inselspital 
Bern CH-3010, Switzerland 
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Technique for one-lung ventilation during video- 
assisted thoracoscopic surgical interruption of 
patent ductus arteriosus in children 
To the Editor: 
Subsequent to the initial half dozen cases of patent 
ductus arteriosus (PDA) done with the use of video- 
assisted thoracoscopic surgery (VATS), we have modi- 
fied the technique of one-lung ventilation for VATS. 
We now achieve right-sided one-lung ventilation by 
intubating the right main-stem bronchus. Right main- 
stem bronchial intubation is performed by insertion of 
a single-lumen endotracheal tube with left-facing bevel 
(with the tip of the endotracheal tube to the right of 
center) deep into the tracheobronchial tree. This results 
in right main-stem intubation in 100% of cases. After 
induction of anesthesia nd endotracheal intubation, 
bilateral air entry is checked and the single-lumen 
endotracheal tube is advanced eeply and then with- 
drawn slowly until breath sounds are heard all over the 
right hemithorax and no breath sounds on the left 
hemithorax. The length of the endotracheal tube 
needed to achieve this single lung ventilation is noted 
on the external surface of the tube, and then the tube is 
withdrawn further to maintain double lung ventilation 
during positioning and draping of the patient. Once 
thoracostomies are performed for VATS, one-lung 
ventilation is achieved by inserting the endotracheal 
tube to a distance noted previously. By means of this 
technique, the left lung is totally unventilated and 
collapsed to the entire satisfaction of the anesthetic and 
surgical team. During one-lung ventilation, the inspired 
oxygen fraction is increased to 100%, tidal volume 
reduced by 20%, and respiratory rate increased by 20%. 
The monitoring includes electrocardiogram, direct ar- 
terial pressure, central venous pressure, pulse oximetry, 
end-tidal carbon dioxide analysis, and blood gas analy- 
sis. This method of one-lung ventilation is simple (no 
extra equipment/bronchoscopy is required) and safe 
(no risk of slippage of the blocker). 
We have used this technique of right main-stem 
intubation for VATS during operations for PDA in 45 
children, ages ranging from 6 months to 9 years (mean 
3.6 years) and weights ranging from 8 to 27 kg (mean 
15.7 kg). Now we are routinely performing PDA clip- 
ping through VATS using right main-stem bronchial 
intubation and have abandoned the new technique of 
one-lung ventilation described by Vakamudi and asso- 
ciates 1in favor of right main-stem bronchial intubation 
for obvious reasons. 
Kanchi Muralidhar, MD 
Shetty Devi Prasad, MS 
B.M. Birla Heart Research Centre 
1H, National Library Ave. 
Calcutta, 700 027, India 
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Tumor dissemination after video-assisted thoracic 
surgery: What does it mean? 
To the Editor: 
We read with interest he recently published article 
on tumor dissemination after video-assisted thoracic 
surgery (VATS) in 21 cases by Downey and colleagues. 1 
The authors conclude that thoracoscopic wedge exci- 
sion of a lung cancer is an inadequate cancer operation 
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and, should a malignant umor be diagnosed uring 
thoracoscopy, a thoracotomy and lobectomy should be 
performed. This recommendation was based on the 
multicenter trial of the Lung Cancer Study Group. z
Several comments on the subject seem appropriate. 
1. Lobectomy and wedge resection are, obviously, two 
different operations, regardless of whether they are 
done by VATS or not. Using the terms VATS lobectomy 
and VATS wedge resection i terchangeably is confusing. 
These two operations cannot be ascribed to one single 
entity called just VATS. It is difficult to draw any 
conclusion from this report because it is unknown which 
VATS procedure was performed in each of the 21 cases. 
However, in three cases, in which the actual VATS 
procedure was specified, it is more likely that dissemi- 
nation was related to wedge resection and segmentec- 
tomy rather than to the method of entering the thoracic 
cavity. This relationship, indeed, has been clearly shown 
by the Lung Cancer Study Group. 2 In this report lesser 
resections (wedge and segmentectomy) were compared 
with lobectomy in the management of stage I non- 
small-cell lung cancers. A 25% increased risk of local 
recurrence in patients who had been randomized to a 
lesser resection was reported. 
2. Regarding the methods used in this report, authors 
surveyed 55 members of the Video-Assisted Thoracic 
Surgery Study Group (VATSSG). The total number of 
procedures performed by the members of the VATSSG 
is unknown. Some of the procedures reported were not 
performed by members of the VATSSG; the operations 
were performed by other surgeons at the same institu- 
tion, or else the patients were referred for postopera- 
tive consultation from other institutions. We agree with 
the authors' statement that this is a voluntary reporting 
based on recollection and should be considered a 
collection of anecdotes. This report of 21 cases, in fact, 
represents a description of a rather diverse group of 18 
patients and three case reports. Inasmuch as this article 
was published as an original communication in the 
Journal, the title of the report could make a misleading 
impression, that it was a result of a study conducted by 
the VATSSG, showing interrelation between dissemi- 
nation and VATS. 
3. Among these 21 cases, only nine represent primary 
lung cancers. A detailed report of one of these nine 
cases has been published before. 3 Five patients had 
disease metastatic to the lung. This means that these 
patients had generalized malignant disease and that 
tumor cells were disseminated by the time of the 
operation. In these five cases, it is unknown whether 
further dissemination was related to VATS or rather to 
an already ongoing generalized malignant process. The 
site of recurrence in one patient with melanoma was 
pleura. This might not be related to the actual opera- 
tion at all. The incision was the site of recurrence in all 
five patients with mesotheliomas. We agree with the 
authors that the propensity for mesotheliomas to grow 
into thoracotomy and chest tube incisions is widely 
recognized and mesotheliomas should be considered 
separately from the other cases. The last two patients 
had small-cell carcinoma and esophageal squamous 
carcinoma. It is impossible to find any interrelation 
between tumor dissemination, recurrence, and the 
VATS procedure in these particular 12 cases ~. 
4. Recurrence in a suture line is most likely the result of 
an inadequate resection and has nothing to do with how 
the specimen is removed. This can happen after wedge 
resection performed through thoracotomy, as well as by 
VATS. 
5. The authors conclude that should a malignant tumor 
be diagnosed uring thoracoscopy, a thoracotomy and 
lobectomy should be performed. However, nothing in this 
report supports the conclusion that thoracotomy is neces- 
sary. 
6. Finally, it is time for all of us to realize that VATS is 
not thoracoscopy. 4 These terms must not be used inter- 
changeably. 
Similar case reports on tumor dissemination by VATS 
have been published. 3'5'6 In all these reports lesser 
resections were performed. In the majority of these cases 
no protective plastic bags were used. In all cases the 
authors blamed VATS rather than its inappropriate ap- 
plication. 
We share the opinion that wedge excision is an inade- 
quate cancer operation. This is true regardless of whether 
VATS or an open technique is used. 
On the contrary, we believe that by using special 
plastic bags and careful handling of the resected 
tissue, dissemination can be avoided during VATS 
lobectomy. Once excised, the specimen must be placed 
in a protective container before removal. We agree with 
Lewis, Caccavale, and Sisler, 7 who adamantly recom- 
mend a sealed container for the removal of all malig- 
nant tissue. 
It is important hat authors reporting similar cases 
specify whether a protective container was used or not 
and which VATS operation was performed--a lobec- 
tomy or wedge resection. It is reasonable to believe that 
dissemination i  these case reports relates to wedge 
resection and segmentectomy rather than to VATS. To 
our knowledge, the literature contains no reports refut- 
ing the opinion that VATS lobectomy with placement 
of the specimen in a sealed container before removal is 
an adequate operation for patients with peripheral T1 
NO M0 non-small-cell lung cancer. 
Ulf Hermansson, MD 
Igor E. Konstantinov, MD 
Claes Ardn, MD, PhD 
Department ofCardiothoracic Surgery 
University Hospital 
S-581 85, LinkOping, Sweden 
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Reply to the Editor: 
We appreciate the comments of Drs. Hermansson, 
Konstantinov, and Aren in response to our article. 
Unfortunately, they have misread our conclusion, which 
may be summarized as follows: The case reports pre- 
sented raise concerns that the techniques of manipula- 
tion of malignant tissue during VATS procedures, 
regardless of the extent of resection, may lead to an 
increased rate of suture line occurrences; this increase 
is the result of inadequate tissue margins caused by an 
inability to palpate extent of disease. Furthermore, the 
reported cases raise concerns that disruption of tumor- 
bearing tissue with implantation within the pleural 
cavity or within chest wall incisions occurs at rates 
higher than seen during open thoracotomy and in- 
trathoracic resections. The technique they recommend 
of placing specimens into sealed bags before withdrawal 
from the chest is reasonable and may spare incisional 
contamination; however, this will not relieve concerns 
regarding inadequate margins or disruption within the 
pleural cavity. 
The morbidity and mortality of open procedures for 
the resection of intrathoracic malignant tumors are well 
documented in the literature, as is the previously 
vanishing rare problem of tumor implantation in an 
incision. Before VATS techniques are generally 
adopted, we advocate well-designed trials that will 
document both that VATS techniques are as safe as 
open techniques and that, stage for stage, VATS tech- 
niques provide 3- and 5-year survivals equal to or better 
than those achieved with open techniques. 
Robert J. Downey, MD 
Patricia McCormack, MD 
Division of Thoracic Surgery, 
Memorial Sloan-Kettering Cancer Center, 
New York, NY 10021 
Joseph LoCicero IlL MD 
Division of Thoracic Surgery 
New England Deaconess Hospital 
Boston, MA 02215 
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Effect of milrinone on coronary artery bypass 
grafts 
To the Editor." 
The effect of vasodilators on coronary artery bypass 
grafts is always an interesting topic because the vaso- 
constriction of the grafts may cause hypoperfusion 
syndrome, which may cause a serious problem in those 
who undergo coronary artery bypass with arterial 
grafts) 
With interest, I have read the article authored by Liu 
and associates a regarding the effect of a relatively new 
vasodilator, the phosphodiesterase II I inhibitor milri- 
none, which also possesses inotropic effects. In their 
study, the authors investigated the effect of milrinone in 
the human internal thoracic artery with regard to the 
vasorelaxant effect and the role of endothelium in such 
effect. Their findings in this article are similar to our 
previous reports in pharmacology journals. 3'4 In our 
reports, we have found that milrinone has vasorelaxant 
effects against all four vasoconstrictors we tested: po- 
tassium, U46619, phenylephrine, and endothelin-1. We 
have also tested the depressant effect of milrinone on 
the contraction induced by these vasoconstrictors. 3 In 
addition, we have found that the vasorelaxant effect of 
milrinone is endothelium independent)  I am glad to 
see that these results have been reconfirmed by Liu and 
his associates. Furthermore, we have discovered that 
milrinone and nitroglycerin have a synergistic effect 
that is clinically very important, because these two 
drugs are sometimes used together in the intensive care 
unit. 
However, on the basis of our findings with regard to 
the effect and the use of milrinone, we would emphasize 
three points: (1) Relaxation of milrinone in the potas- 
sium-precontracted internal thoracic artery is complete 
at the highest concentration ( -4  log M), although the 
sensitivity to this agent is lower (less potent) than to the 
other three agents. This demonstrates the selectivity of 
the vasorelaxant effect of this vasodilator. (2) The 
inhibitory effect of milrinone in the contraction induced 
by the four important vasoconstrictors is also slightly 
selective. It was more potent in inhibition of the 
receptor-mediated (by endothelin-1 and phenyleph- 
rine) than the depolarizing agent potassium-mediated 
contraction (Fig. 1). This is shown by the more signifi- 
cant suppression effect in the contraction induced by 
endothelin-1 and phenylephrine) (3) There is a syner- 
gistic vasorelaxant effect of the phosphodiesterase II I 
inhibitor milrinone and the nitrovasodilator nitroglyc- 
erin in human conduit arteries. This effect may be 
beneficial to patients undergoing coronary artery bypass 
grafting and to other patients requiring these vasodila- 
tors. Reduced doses of the vasodilators may be suffi- 
cient to produce vasodilatation similar to that produced 
by either of them alone at higher concentrations (Fig. 
2) .4 
On the basis of this information, we would suggest 
clinical considerations and indications for the use of 
milrinone after coronary artery bypass grafting as fol- 
lows: 
1. The use of milrinone is best indicated when the 
